Increased induction of inducible nitric oxide synthase expression in aortae of type 2 diabetes rats

Journal of Pharmacological Sciences

Volumn 107, Issue 2, 2008, Pages 190-200

  Takahashi, Yuji ^a   Nakano, Tomoyuki ^a   Wakabayashi, Ichiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Artery; Glucose; Lipopolysaccharide; Nitric oxide synthase; Type 2 diabetes

Indexed keywords

CYCLOHEXIMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; VASOCONSTRICTION; VASODILATATION;

EID: 46449122433     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0080010     Document Type: Article

References (28)

1. Hostetter MK. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes. 1990;39:271-275.
2. Wenzel RP. The mortality of hospital-acquired bloodstream infections: need for a new vital statistic? Int J Epidemiol. 1988;17:225-227.
3. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
4. Thiemermann C. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol. 1994;28:45-79.
5. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995;81:641-650.
6. Oyama Y, Kawasaki H, Hattori Y, Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol. 1986;131:75-78.
7. Kamata K, Miyata N, Abiru T, Kasuya Y. Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci. 1992;50:1379-1387.
8. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567-574.
9. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510-2516.
10. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992;90:2548-2554.
11. Hattori Y, Kawasaki H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol. 1991;261:H1086-H1094.
12. Diederich D, Skopec J, Diederich A, Dai FX. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol. 1994;266:H1153-H1161.
13. Takahashi Y, Negoro M, Wakabayashi I. Decreased modulation by lipopolysaccharide of aortic smooth muscle contractility in streptozotocin- induced hyperglycemic rats. J Cardiovasc Pharmacol. 2003;41:162-170.
14. Kimura K, Toyota T, Kakizaki M, Kudo M, Takebe K, Goto Y. Impaired insulin secretion in the spontaneous diabetes rats. Tohoku J Exp Med. 1982;137:453-459.
15. Suzuki K, Goto Y, Toyota T. Spontaneously diabetic GK (Goto-Kakizaki) rats. In: Shafrir Smith-Gordon E, editor. Lessons from animal diabetes IV. Great Britain; 1993. p. 107-111.
16. Stockklauser-Färber K, Ballhausen T, Laufer A, Rösen P. Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim Biophys Acta. 2000;1535:10-20.
17. Korolkiewicz R, Rekowski P, Szyk A, Kato S, Yasuhiro T, Kubomi M, et al. Effects of diabetes mellitus on the contractile activity of carbachol and galanin in isolated gastric fundus strips of rats. Pharmacology. 1998;57:65-78.
18. Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide. 2000;4:590-596.
19. Sagara M, Satoh J, Zhu XP, Takahashi K, Fukuzawa M, Muto G, et al. Inhibition with N-acetylcysteine of enhanced production of tumor necrosis factor in streptozotocin-induced diabetic rats. Clin Immunol Immunopathol. 1994;71:333-337.
20. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes. 1994;43:1271-1278.
21. Pacheco ME, Beltrán A, Redondo J, Manso AM, Alonso MJ, Salaices M. High glucose enhances inducible nitric oxide synthase expression. Role of protein kinase C-βII. Eur J Pharmacol. 2006;538:115-123.
22. Kleschyov AL, Muller B, Schott C, Stoclet JC. Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta. Br J Pharmacol. 1998;124:623-626.
23. Shimizu S, Ishii M, Kawakami Y, Kiuchi Y, Momose K, Yamamoto T. Presence of excess tetrahydrobiopterin during nitric oxide production from inducible nitric oxide synthase in LPS-treated rat aorta. Life Sci. 1999;65:2769-2779.
24. Zhang H, Du Y, Cohen RA, Chobanian AV, Brecher P. Adventitia as a source of inducible nitric oxide synthase in the rat aorta. Am J Hypertens. 1999;12:467-475.
25. Wakabayashi I, Hatake K, Kakishita E, Nagai K. Diminution of contractile response of the aorta from endotoxin-injected rats. Eur J Phamacol. 1987;141:117-122.
26. Sotoda Y, Shimazaki Y, Wakabayashi I. Nitric oxide-dependent and -independent inhibition by lipopolysaccharide of phosphoinositide hydrolysis in vascular smooth muscle. Life Sci. 2001;69:2845-2854.
27. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol. 2005;511:53-64.
28. 2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats. Am J Physiol Heart Circ Physiol. 2004;287:H135-H143.